More articles from Article

Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors
Shinji Sakai, Kenji Kawabata, Shinji Tanaka, Norifumi Harimoto, Ichiro Hashimoto, Changjun Mu, Brian Salmons, Hiroyuki Ijima, Koei Kawakami

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1786-1790; DOI: 10.1158/1535-7163.MCT-05-0227
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
Fiona A. Harding, Amy D. Liu, Marcia Stickler, O. Jennifer Razo, Regina Chin, Nargol Faravashi, Wendy Viola, Tom Graycar, V. Pete Yeung, Wolfgang Aehle, Daan Meijer, Stephanie Wong, M. Harunur Rashid, Ana M. Valdes, Volker Schellenberger

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1791-1800; DOI: 10.1158/1535-7163.MCT-05-0189
A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells
Kazuki Yamanaka, Palma Rocchi, Hideaki Miyake, Ladan Fazli, Bob Vessella, Uwe Zangemeister-Wittke, Martin E. Gleave

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1689-1698; DOI: 10.1158/1535-7163.MCT-05-0064
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak
Shivendra V. Singh, Yan Zeng, Dong Xiao, Victor G. Vogel, Joel B. Nelson, Rajiv Dhir, Yamini B. Tripathi

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1747-1754; DOI: 10.1158/1535-7163.MCT-05-0223
Role of O⁶-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine
Kimiko Ishiguro, Krishnamurthy Shyam, Philip G. Penketh, Alan C. Sartorelli

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1755-1763; DOI: 10.1158/1535-7163.MCT-05-0169
Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells
Hiroji Uemura, Hitoshi Ishiguro, Yoji Nagashima, Takeshi Sasaki, Noboru Nakaigawa, Hisashi Hasumi, Shingo Kato, Yoshinobu Kubota

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1699-1709; DOI: 10.1158/1535-7163.MCT-04-0295
Imaging androgen receptor function during flutamide treatment in the LAPC9 xenograft model
Romyla Ilagan, Liquin Joann Zhang, Jill Pottratz, Kim Le, Sussan Salas, Meera Iyer, Lily Wu, Sanjiv S. Gambhir, Michael Carey

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1662-1669; DOI: 10.1158/1535-7163.MCT-05-0197
Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo
Stephan A. Vorburger, Nophadol Hetrakul, Weiya Xia, Marcia Wilson-Heiner, Nadeem Mirza, Raphael E. Pollock, Barry Feig, Stephen G. Swisher, Kelly K. Hunt

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1710-1716; DOI: 10.1158/1535-7163.MCT-05-0036
Biological and molecular properties of a new α_vβ₃/α_vβ₅ integrin antagonist
Laura Belvisi, Teresa Riccioni, Marcella Marcellini, Loredana Vesci, Ilaria Chiarucci, Daniela Efrati, Donatella Potenza, Carlo Scolastico, Leonardo Manzoni, Katia Lombardo, M. Antonietta Stasi, Augusto Orlandi, Alessandro Ciucci, Beatrice Nico, Domenico Ribatti, Giuseppe Giannini, Marco Presta, Paolo Carminati, Claudio Pisano

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1670-1680; DOI: 10.1158/1535-7163.MCT-05-0120
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion
Alexandre Kaliski, Laurence Maggiorella, Keith A. Cengel, Denis Mathe, Valerie Rouffiac, Paule Opolon, Nathalie Lassau, Jean Bourhis, Eric Deutsch

Molecular Cancer Therapeutics Nov 2005, 4 (11) 1717-1728; DOI: 10.1158/1535-7163.MCT-05-0179

Main menu

User menu

Search

More articles from Article

Pages

Articles

Info for

About MCT